| ²é¿´: 13914 | »Ø¸´: 458 | ||||||||||||||||||||||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û254´Î£¬×÷ÕßsakfyÔö¼Ó½ð±Ò 200.6 ¸ö | ||||||||||||||||||||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||||||||||||||||||||
[×ÊÔ´]
·ÖÏíÌÀÉ·͸2013Äê56¸öÐÂÒ©·ÖÎö±¨¸æÍêÕû°æ(Ó¢ÎÄ)
|
||||||||||||||||||||||
| This article provides a comprehensive overview of the 56 new drugs and biologics introduced for the first time in 2013, the largest number in at least a decade.This includes 20 new orphan drugs and 10 first-in-class agents, as well as the first three products bearing the FDA¡¯s new Breakthrough Therapy Designation.The review also covers 30 important new line extensions, encompassing new indications,new formulations and new combinations of previously marketed agents.In addition to this bumper crop of new launches, another 19 products were approved for the first time during the year but not yet launched by the close of this article; these new products are also discussed. |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : ÌÀÉ·͸2013Äê56¸öÐÂÒ©·ÖÎö±¨¸æÍêÕû°æ.pdf
2014-02-26 18:16:23, 3.62 M
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
¾µä×ÊÔ´Ìû | ÐÂÒ©Ñз¢±Ø±¸×ÊÁÏ | SCIÊÕ¼ | Ò©Îï×¢²áÉ걨×ÊÁÏ |
Ò©ÎïºÏ³É | ʵÑéʹÊ---ÒªÃüѽ | ÐÂÒ©¶¯Ì¬ | ×ÊÔ´¿â |
ÎÒ°®Í¶×Ê | Ò©ÎïºÏ³É | ÐÂÒ©Ñз¢»ù´¡ | ÐÅÏ¢µ÷ÑÐ |
СÉúÒ»¼ | ÊÕ²Ø | ziliao | ºéÑ«¾«Ñ¡ |
ÐÂÒ©Ñз¢-Ïà¹Ø | Éú»î | ×¢²á | Êé¼® |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
ҩѧ¿¼Ñе÷¼Á
ÒѾÓÐ0È˻ظ´
»ªÄÏÀí¹¤´óѧ-ҽѧԺ-ҩѧר˶ÉÙÁ¿µ÷¼ÁÃû¶î
ÒѾÓÐ28È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ251È˻ظ´
ÇóÖú¡¶ÉúÎïÀûÓöȺÍÉúÎïµÈЧÐÔÑо¿Ö¸µ¼ÔÔò¡·£¨ÊÔ ÐУ©£¬2002
ÒѾÓÐ0È˻ظ´
ÎÄÏ×ÇóÖú
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇóÖúË÷ÀûÄÇУ¨solifenacin£©ºÍÅÁÁ¢¹Ç»¯´¼£¨paricalcitol£© µÄÌÀÉ·͸±¨¸æ
ÒѾÓÐ8È˻ظ´
ÌÀÉ·͸2014ÐèÒªÖØµã¹Ø×¢µÄÒ©Îï
ÒѾÓÐ449È˻ظ´
2013µÚÈý¼¾¶Èҩҵй۲죨Thomson Reuters£©ÒÔ¼°2013Äê1-3¼¾¶ÈµÄ·ÂÖÆÒ©·¢Õ¹¶¯Ì¬
ÒѾÓÐ72È˻ظ´
ÌÀÉ·͸-Ç°ÑØ×¨Ìâ-ÉêÇëÔÚÏÈÔÔò¼°ºóÐø¹¤×÷£º×¨ÀûÌôÕ½µÄÉÌÒµÕ½ÂÔ¡¾ÖÐÎÄ¡¿¡¾ÎÞÖØ¸´¡¿
ÒѾÓÐ99È˻ظ´
ÌÀÉ·͸-°×ƤÊé¡¶¹Â¶ùÒ©µÄ¾Þ´óÉÌҵDZÁ¦¡·¡¾ÖÐÎÄ¡¿¡¾ÒÑËÑË÷ÎÞÖØ¸´¡¿
ÒѾÓÐ75È˻ظ´
ÌÀÉ·͸-¡¶·ÂÖÆÒ©·¢Õ¹¶¯Ì¬¡·-2013µÚÒ»¼¾¶È¡¾ÖÐÎÄ¡¿¡¾ÒÑËÑË÷ÎÞÖØ¸´¡¿
ÒѾÓÐ60È˻ظ´
ÌÀÉ·͸-´óÊý¾Ý¶ÔÖÆÒ©ÒµµÄ¿ÉÄÜÓ°Ïì-BigDataWhitePape¡¾ÖÐÎÄ¡¿¡¾ÒÑËÑË÷ÎÞÖØ¸´¡¿
ÒѾÓÐ85È˻ظ´
½ØÖ¹2012µ×È«ÇòÐÂÒ©Ñз¢×ܽᣨÌÀÉ·͸°æ±¾£©
ÒѾÓÐ172È˻ظ´
ÌÀÉ·͸-Ò©ÎﻯѧÔÚÑз¢½ÇÉ«µÄת±ä£¨2013Äê6ÔÂ7ÈÕ £©¡¾ÒÑËÑË÷ÎÞÖØ¸´¡¿
ÒѾÓÐ164È˻ظ´
ÇóÖúÌÀÉ·͸ҩÎïÑо¿±¨¸æ
ÒѾÓÐ4È˻ظ´
ËÖ÷³Á¸¡ ¡ª¡ªÐÂÒ©Ñз¢µÄÁ¢ÏîºÍ×·×Ù(ÕÅ »Ô ÌÀÉ·͸)
ÒѾÓÐ293È˻ظ´
41Â¥2014-02-28 08:33:29
1949stone
ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 95 (³õÖÐÉú)
- ¹ó±ö: 2.38
- ½ð±Ò: 2633.7
- Ìû×Ó: 9831
- ÔÚÏß: 2692.8Сʱ
- ³æºÅ: 765987
3Â¥2014-02-26 19:24:18
¼òµ¥»Ø¸´
Cruise20142Â¥
2014-02-26 18:34
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
XJP10074Â¥
2014-02-26 23:39
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
sjshvdc5Â¥
2014-02-26 23:45
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
bluesky99996Â¥
2014-02-27 07:43
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
yanzr7Â¥
2014-02-27 08:08
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
voyager888Â¥
2014-02-27 08:25
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
cateye9Â¥
2014-02-27 08:27
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
TracyTom1610Â¥
2014-02-27 08:38
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
º£Ë®ÕýÀ¶887111Â¥
2014-02-27 08:47
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
ananfg12Â¥
2014-02-27 08:55
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
Çà̦ÉÁÖ13Â¥
2014-02-27 09:18
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
yc198414Â¥
2014-02-27 09:55
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡














»Ø¸´´ËÂ¥
daweiliu18